Skip to content
Erudio Health
menu
Clinical trial · no report yet · Phase not applicable

NORDIC-SUN

Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial

We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.

Preliminary discovery

Commentary in our index that names this trial so far

Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.

ChannelFound
X threads14
Bluesky threads1

The trial

ClinicalTrials.gov
Official title
Multicenter Randomized Trial of Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma Receiving Checkpoint Inhibitors: a Trial Evaluating the Impact of Surgery or No Surgery. The NORDIC-SUN-Trial
Phase
Phase not applicable
Status
Recruiting
Conditions
Kidney Cancer; Renal Cell Carcinoma Metastatic; Synchronous Neoplasm
Interventions
Cytoreductive nephrectomy; Tissue sampling
Arms
  • Deferred nephrectomy · Experimental
  • No surgery · Active comparator
Enrollment
400 (estimated)
Primary outcomes
  • Overall survival
Sponsor
Niels Fristrup with Aarhus University Hospital
Start
Jul 6, 2020
Primary completion
Dec 1, 2028 (estimated)
Results posted
No
Registry record
NCT03977571 · updated Sep 23, 2026

Publications

linked from the registry
  • Flammia RS, Campi R, Bologna E, Bertolo R, Leonardo C, Calabro F, Amparore D, Simone G; Young Academic Urologists (YAU) Renal Cancer Working Group. Cytoreductive nephrectomy in the era of immune-checkpoint inhibitors: back to the future? BJU Int. 2026 May;137(5):763-769. doi: 10.1111/bju.70168. Epub 2026 Feb 11. PubMed 41673778
  • Iisager L, Ahrenfeldt J, Donskov F, Ljungberg B, Bex A, Lund L, Lyskjaer I, Fristrup N. Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial. BMC Cancer. 2024 Feb 24;24(1):260. doi: 10.1186/s12885-024-11987-3. PubMed 38402173
  • Kuusk T, Abu-Ghanem Y, Mumtaz F, Powles T, Bex A. Perioperative therapy in renal cancer in the era of immune checkpoint inhibitor therapy. Curr Opin Urol. 2021 May 1;31(3):262-269. doi: 10.1097/MOU.0000000000000868. PubMed 33742979